Edwin L. Solot, Jr. Maintains Significant Stake in Sensus Healthcare
Ticker: SRTS · Form: SC 13G/A · Filed: Feb 6, 2024 · CIK: 1494891
| Field | Detail |
|---|---|
| Company | Sensus Healthcare, Inc. (SRTS) |
| Form Type | SC 13G/A |
| Filed Date | Feb 6, 2024 |
| Risk Level | low |
| Pages | 3 |
| Reading Time | 4 min |
| Key Dollar Amounts | $0.01 |
| Sentiment | neutral |
Complexity: simple
Sentiment: neutral
Topics: insider-ownership, amendment, passive-investing
TL;DR
**Solot still holds a big chunk of Sensus Healthcare, signaling confidence.**
AI Summary
Edwin L. Solot, Jr. filed an amended SC 13G/A on February 6, 2024, indicating his beneficial ownership of Sensus Healthcare, Inc. common stock as of December 31, 2023. This filing updates previous disclosures, confirming his continued significant stake in the company. For investors, this matters because a large individual shareholder like Solot can influence company decisions and signals a continued belief in the company's value, potentially impacting stock sentiment.
Why It Matters
This filing confirms a key individual investor's continued substantial ownership, which can be a vote of confidence in Sensus Healthcare's future and potentially influence its strategic direction.
Risk Assessment
Risk Level: low — This is an amendment to a passive ownership filing, indicating no immediate change in control or significant new risk.
Analyst Insight
Investors should note the continued presence of a significant individual shareholder, Edwin L. Solot, Jr., which can be a positive signal of long-term belief in Sensus Healthcare, Inc. However, this filing itself doesn't indicate any new buying or selling activity, so further research into Solot's historical actions and the company's fundamentals is warranted.
Key Players & Entities
- Edwin L. Solot, Jr. (person) — reporting person and beneficial owner
- Sensus Healthcare, Inc. (company) — the issuer of the securities
- December 31, 2023 (date) — date of event requiring the filing
- February 6, 2024 (date) — filing date of the SC 13G/A
FAQ
Who is the reporting person in this SC 13G/A filing?
The reporting person in this SC 13G/A filing is Edwin L. Solot, Jr., as stated in Item 1 of the cover page and the 'FILED BY' section.
What is the name of the issuer whose securities are being reported?
The name of the issuer is Sensus Healthcare, Inc., as clearly stated in the 'SUBJECT COMPANY' data and the title of the filing.
What is the CUSIP number for the class of securities reported?
The CUSIP number for the Common Stock, $0.01 par value, of Sensus Healthcare, Inc. is 81728J109, as listed on the cover page.
What was the date of the event that required this filing?
The date of the event which required the filing of this statement was December 31, 2023, as indicated on the cover page of the filing.
Under which rule of the Securities Exchange Act of 1934 was this Schedule filed?
This Schedule was filed under Rule 13d-1(c) of the Securities Exchange Act of 1934, as indicated by the checked box on the cover page.
Filing Stats: 1,000 words · 4 min read · ~3 pages · Grade level 7.2 · Accepted 2024-02-06 12:27:47
Key Financial Figures
- $0.01 — Inc. (Name of Issuer) Common Stock, $0.01 par value (Title of Class of Securiti
Filing Documents
- formsc13ga.htm (SC 13G/A) — 78KB
- 0001493152-24-005060.txt ( ) — 79KB
From the Filing
SC 13G/A 1 formsc13ga.htm UNITED SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G/A Under the Securities Exchange Act of 1934 (Amendment No. 3)* Sensus Healthcare, Inc. (Name of Issuer) Common Stock, $0.01 par value (Title of Class of Securities) 81728J109 (CUSIP Number) Edwin L. Solot, Jr. 10940 Wilshire Boulevard Suite 1600 PMG #874 Los Angeles, CA 90024 (310) 471-6634 (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications) December 31, 2023 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: Rule 13d-1(b) Rule 13d-1(c) Rule 13d-1(d) * The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page. The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). CUSIP No. 81728J109 1. NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) Edwin L. Solot, Jr. 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (see instructions) (a) (b) 3. SEC USE ONLY 4. CITIZENSHIP OR PLACE OF ORGANIZATION United NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 5. SOLE VOTING POWER 1,522,081 6. SHARED VOTING POWER 11,200 (1) 7. SOLE DISPOSITIVE POWER 1,522,081 8. SHARED DISPOSITIVE POWER 11,200 (1) 9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 1,533,281 10. CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (see instructions) 11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 9.36% (2) 12. TYPE OF REPORTING PERSON (see instructions) IN (1) Represents shares of the issuer’s common stock held of record by the reporting person’s spouse. The reporting person may be deemed to be the beneficial owner of such shares. (2) Based on 16,382,404 shares of the issuer’s common stock outstanding as of November 3, 2023, as reported on the issuer’s Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission (the “SEC”) on November 13, 2023. Item 1. (a) Name of Issuer Sensus Healthcare, Inc. (b) Address of Issuer’s Principal Executive Offices 851 Broken Sound Pkwy., NW #215 Boca Raton, FL 33487 Item 2. (a) Name of Person Filing Edwin L. Solot, Jr. (b) Address of the Principal Office or, if none, residence 10940 Wilshire Boulevard Suite 1600 PMG #874 Los Angeles, CA 90024 (c) Citizenship United (d) Title of Class of Securities Common Stock, par value $0.01 (e) CUSIP Number 81728J109 Item 3. If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a: (a) Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o). (b) Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c). (c) Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c). (d) Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8). (e) An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E); (f) An employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F); (g) A parent holding company or control person in accordance with §240.13d-1(b)(1)(ii)(G); (h) A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813); (i) A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3); (j) Group, in accordance with §240.13d-1(b)(1)(ii)(J). Item 4. Ownership. Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1. (a) Amount beneficially owned: 1,533,281 (b) Percent of class: 9.36% (c) Number of shares as to which the person has: (i) Sole power to vote or to direct the vote: 1,522,081 (ii) Shared power to vote or to direct the vote: 11,200 (1) (iii) Sole power to dispose or to direct the disposition of: 1,522,081 (iv) Shared power to dispose or to direct the disposition of: 11,200 (1) (1) Represents shares of the issuer’s common stock held of record by the reporting person’s spouse. The reporting person may be deemed to be the beneficial o